Health
From The Report: Kuwait 2018
View in Online Reader

The health profile of the Kuwaiti population has changed significantly in the past several decades. Kuwaiti citizens, who account for around 30% of the population of just over 4.2m, have become more prone to non-communicable diseases (NCDs). While deaths from infectious diseases are posing less and less of a threat, NCDs – the four main categories of which are heart disease, cancers, diabetes and upper respiratory diseases – accounted for 72% of deaths in Kuwait in 2015, according to the World Bank. In the coming years the government will aim to address the increasing prevalence of NCDs, which are also associated with rising health care costs. Efforts to reduce public health care expenditures will also require a shift in the financing of care for the large expatriate population, and solutions for this challenge are now being formulated.

Articles from this Chapter

Overview

Long-term progress: New initiatives focus on increasing capacity and addressing the rising rate of chronic disease
OBG
plus

The health profile of the Kuwaiti population has changed significantly in the past several decades. Kuwaiti citizens, who account for around 30% of the population of just over 4.2m, have become more prone to non-communicable diseases (NCDs). While deaths from infectious diseases are posing less and less of a threat, NCDs – the four main categories of which are heart disease, cancers, diabetes and upper respiratory diseases – accounted for 72% of deaths in Kuwait in 2015, according to…

Overview

Promoting pharmaceuticals: As health care provision expands, demand for both local and imported pharmaceutical products is rising
OBG
plus

In recent decades, the pharmaceutical market has expanded its geographical reach. This trend appears to be here to stay; in a survey of major pharmaceutical firms conducted by global consulting firm PwC’s Strategy& team, more than half of respondents anticipated that over 30% of their global sales would originate in emerging markets by 2018. Even in the most newly opened markets, drug companies have seen growth: forecasts for Myanmar, for instance, indicate that pharmaceuticals could quickly grow into a $1bn industry. As governments and companies continue to take note of this high-potential sector, both are pursuing development…

Overview

Promoting pharmaceuticals: As health care provision expands, demand for both local and imported pharmaceutical products is rising
OBG
plus

In recent decades, the pharmaceutical market has expanded its geographical reach. This trend appears to be here to stay; in a survey of major pharmaceutical firms conducted by global consulting firm PwC’s Strategy& team, more than half of respondents anticipated that over 30% of their global sales would originate in emerging markets by 2018. Even in the most newly opened markets, drug companies have seen growth: forecasts for Myanmar, for instance, indicate that pharmaceuticals could quickly grow into a $1bn industry. As governments and companies continue to take note of this high-potential sector, both are pursuing development…